William E. Duke - 01 Sep 2021 Form 4 Insider Report for Kaleido Biosciences, Inc.

Role
Chief Financial Officer
Signature
/s/ William Duke, Jr.
Issuer symbol
N/A
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 16:16:58 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 01 Sep 2021 Common Stock 60,000 $6.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on September 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.